Personal opinion is that these mega companies are not dumb - with all the negative evidence against tanezumab thus far, there is still a glimmer of light at the end of the tunnel - now they may be advocating a continuing process to provide an element of doubt into the minds of investors to keep a lid on the speculation around other potential players in the OA areas - not least of which is PAR.
If so, why?
Could Eli Lilly/Pfizer be a potential match to PAR down the track, after phase III is underway?
I am not usually into all the conspiracy theories around, but at least one of the majors is surely likely to take PAR out at some stage, and if the tanezumab trial results are so poor, what else is motivating pressing ahead? If in fact they are pressing ahead, rather than just saying they are!
Fun and games, and probably still a year or more before any substantive action or indication.
Just a brain dump - have a good day all.
Cabe
- Forums
- ASX - By Stock
- PAR
- research reports and media
research reports and media, page-46
-
- There are more pages in this discussion • 4,383 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
-0.015(6.98%) |
Mkt cap ! $70.04M |
Open | High | Low | Value | Volume |
21.0¢ | 21.0¢ | 20.0¢ | $201.6K | 994.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 429247 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.0¢ | 13806 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 389247 | 0.200 |
8 | 133607 | 0.195 |
17 | 238789 | 0.190 |
4 | 92160 | 0.185 |
8 | 122773 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.210 | 13806 | 2 |
0.215 | 28509 | 1 |
0.220 | 59615 | 6 |
0.225 | 28604 | 2 |
0.230 | 16334 | 2 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
PAR (ASX) Chart |